Loading...
See More

Cipla Medpro under investigation

Sep 21 2012 17:50 I-Net Bridge

Related Articles

Date set for Cipla CEO hearing

Cipla mum on why it suspended CEO

Cipla shares plummet on CEO suspension

Cipla Medpro suspends CEO

Cipla warns on earnings drop

Cipla Medpro expects profit hike

 
Johannesburg - Pharmaceutical group Cipla Medpro South Africa [JSE:CMP) said on Friday it had received notification from the Takeover Regulation Panel (TRP) that it intended to conduct an investigation into the affairs of the company relating to a potential affected transaction.

The complaint was lodged on behalf of certain shareholders‚ among whom includes the company’s suspended CEO.

The details of the other shareholders have not yet been disclosed to the TRP.

“The company has confirmed to the TRP that it will cooperate in any way possible to ensure this matter is resolved as quickly as possible.

*Follow Fin24 on Twitter, Facebook, Google+ and Pinterest.
health
NEXT ON FIN24X

Court rejects Bayer's appeal

2014-12-14 21:15

 

Lastest Articles

Here is how to check your credit score and manage it Read More...
Top tips to save money over the festive period Read More...
These are the top 5 most fuel efficient cars in SA Read More...
What to consider when switching medical aid schemes Read More...
 
 

Read Fin24’s Comments Policy

24.com publishes all comments posted on articles provided that they adhere to our Comments Policy. Should you wish to report a comment for editorial review, please do so by clicking the 'Report Comment' button to the right of each comment.

Comment on this story
0 comments
Add your comment
Comment 0 characters remaining
 

Company Snapshot

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...
Loading...